← Back to Clinical Trials
Recruiting NCT03789383

NCT03789383 Risk Factors and Outcome of Biliary Complications Following Adult Living Donor Liver Transplantation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT03789383
Status Recruiting
Phase
Sponsor Assiut University
Condition Liver Transplant; Complications
Study Type OBSERVATIONAL
Enrollment 50 participants
Start Date 2024-01-01
Primary Completion 2027-01-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 50 participants in total. It began in 2024-01-01 with a primary completion date of 2027-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Liver transplantation (LT) is a live-saving therapy for patients with complicated chronic liver diseases and acute liver failure .Even though many complications can occur after LT, biliary complications (BC) are both common and potentially severe . a prospective study and retrospective part from hospital records. Aim of the study: 1. Detect frequency, risk factors for development of biliary complications post living donor liver transplantation, types (stricture anastomotic or not, leak, biloma, stone, cholangitis etc.…). 2. Evaluate outcomes of different biliary complications

Eligibility Criteria

Inclusion Criteria: * Adults more than 18 y with living donor liver transplantation in Al-Rajhy liver hospital , Assiut university,Egypt Exclusion Criteria: * pediatric liver transplantation * cadaveric liver transplantation

Contact & Investigator

Central Contact

Sara Sedeek

✉ sara_ali@aun.edu.eg

📞 +201022177340

Frequently Asked Questions

Who can join the NCT03789383 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Liver Transplant; Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT03789383 currently recruiting?

Yes, NCT03789383 is actively recruiting participants. Contact the research team at sara_ali@aun.edu.eg for enrollment information.

Where is the NCT03789383 trial being conducted?

This trial is being conducted at Asyut, Egypt, Asyut, Egypt.

Who is sponsoring the NCT03789383 clinical trial?

NCT03789383 is sponsored by Assiut University. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology